Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.1%
- Check12 days agoChange DetectedThe page has been updated to reflect new dates and a revision change from v3.0.0 to v3.0.1, indicating a recent update.SummaryDifference0.4%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as a focus on various radiation therapy techniques and related terms. Notably, the previous mention of lung cancer and certain antineoplastic agents has been removed.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check47 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.